Efficacy of Ban-Qin-Fei-Re-Qing oral liquid on avian infectious bronchitis
Abstract Infectious bronchitis virus (IBV) can cause respiratory infections in animals that often lead to heavy losses for breeding industry. Ban-Qin-Fei-Re-Qing oral liquid (BQ), a Chinese herbal compound, has been used to treat infectious bronchitis (IB). This research aimed to assess the antiviral effect of BQ against IBV and elucidate the underlying mechanisms through bioinformatics analysis. The experiments designed in this study investigated how BQ inhibits IBV propagation in chicken embryos and enhances protective effects on chicken embryos. The findings indicated that, in comparison to the model group (untreated), the BQ-treated groups exhibited a significant protective effect on IBV-infected chicken embryos. Moreover, the groups administered medium or high doses of BQ demonstrated a superior protective effect compared to the group treated with a lower dose. In addition, even at a low dose (2.5 mL/L), BQ successfully treated IB in chickens. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses revealed that the differentially expressed genes were enriched in antiviral pathways, such as the JAK/STAT and type I interferon signaling pathways. In conclusion, the current study demonstrated that BQ has antiviral activity and plays an antiviral role through the combined action of multiple antiviral pathways. These findings could lead to future research on identifying drugs to prevent and treat IB..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
|---|---|
| Enthalten in: |
One Health Advances - 2(2024), 1 vom: 09. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ma, Danyang [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Ban-Qin-Fei-Re-Qing oral liquid |
|---|
| Anmerkungen: |
© The Author(s) 2024 |
|---|
| doi: |
10.1186/s44280-024-00041-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR055464084 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR055464084 | ||
| 003 | DE-627 | ||
| 005 | 20240409064807.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240409s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s44280-024-00041-3 |2 doi | |
| 035 | |a (DE-627)SPR055464084 | ||
| 035 | |a (SPR)s44280-024-00041-3-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ma, Danyang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Efficacy of Ban-Qin-Fei-Re-Qing oral liquid on avian infectious bronchitis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2024 | ||
| 520 | |a Abstract Infectious bronchitis virus (IBV) can cause respiratory infections in animals that often lead to heavy losses for breeding industry. Ban-Qin-Fei-Re-Qing oral liquid (BQ), a Chinese herbal compound, has been used to treat infectious bronchitis (IB). This research aimed to assess the antiviral effect of BQ against IBV and elucidate the underlying mechanisms through bioinformatics analysis. The experiments designed in this study investigated how BQ inhibits IBV propagation in chicken embryos and enhances protective effects on chicken embryos. The findings indicated that, in comparison to the model group (untreated), the BQ-treated groups exhibited a significant protective effect on IBV-infected chicken embryos. Moreover, the groups administered medium or high doses of BQ demonstrated a superior protective effect compared to the group treated with a lower dose. In addition, even at a low dose (2.5 mL/L), BQ successfully treated IB in chickens. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses revealed that the differentially expressed genes were enriched in antiviral pathways, such as the JAK/STAT and type I interferon signaling pathways. In conclusion, the current study demonstrated that BQ has antiviral activity and plays an antiviral role through the combined action of multiple antiviral pathways. These findings could lead to future research on identifying drugs to prevent and treat IB. | ||
| 650 | 4 | |a Ban-Qin-Fei-Re-Qing oral liquid |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Infectious bronchitis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Gene expression profiling |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a JAK/STAT signaling pathways |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Type I interferon signaling pathway |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Gao, Xueyan |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Pingping |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Fenfang |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Tingting |e verfasserin |4 aut | |
| 700 | 1 | |a Fan, Yimeng |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Xiaoqin |e verfasserin |4 aut | |
| 700 | 1 | |a Xie, Huisheng |e verfasserin |4 aut | |
| 700 | 1 | |a Hao, Zhihui |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t One Health Advances |d BioMed Central, 2023 |g 2(2024), 1 vom: 09. Apr. |w (DE-627)SPR049879553 |x 2731-9970 |7 nnns |
| 773 | 1 | 8 | |g volume:2 |g year:2024 |g number:1 |g day:09 |g month:04 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s44280-024-00041-3 |m X:VERLAG |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 2 |j 2024 |e 1 |b 09 |c 04 | ||